This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Hiroshi Murakami, PhD
Professor, Department of Biomolecular Engineering at Nagoya University
Speaker

Profile

Hiroshi Murakami received his Ph.D. from Okayama University in 2000. He was awarded a post-doctoral research fellowship by the Japan Society for the Promotion of Science (JSPS) for the years 2000–2002, for his work with Prof. Masahiko Sisido at Okayama University and Prof. Hiroaki Suga at the State University of New York. In 2003, he joined the University of Tokyo as an assistant professor and was promoted to associate professor in 2009. In 2015, he moved to Nagoya University as a professor. His research focuses on engineering a translation system for the in vitro selection of antibody-like proteins with potential biological and bio-analytical applications.

Agenda Sessions

  • Antibody-like Proteins Targeting Proteins and Small Molecules

    17:00